Tarsus Pharmaceuticals Inc Working Capital to Net Assets Ratio
Tarsus Pharmaceuticals Inc working capital to net assets ratio. Tarsus Pharmaceuticals Inc (TARS) has a Working Capital to Net Assets ratio of 111.4% as of June 2026. Working capital of $386.24 Million (current assets of $561.99 Million minus current liabilities of $175.75 Million) is measured against net assets of $346.73 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Tarsus Pharmaceuticals Inc (2018–2025)
Working capital to net assets ratio of Tarsus Pharmaceuticals Inc from 2018 to 2025. This chart shows how Tarsus Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2018 to 2025. As of June 2026, the ratio stands at 111.4%, reflecting working capital of $386.24 Million against net assets of $346.73 Million USD. Explore Tarsus Pharmaceuticals Inc (TARS) investment intensity to see how much of total assets are deployed in long-term investments.
Tarsus Pharmaceuticals Inc Working Capital to Net Assets Ratio by Year (2018–2025)
Tarsus Pharmaceuticals Inc working capital to net assets ratio by year from 2018 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Tarsus Pharmaceuticals Inc from 2018 to 2025, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see TARS total asset value.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 112.7% | $387.09 Million | $343.43 Million | $522.78 Million | $135.69 Million | ▼ -10.2 pp |
| 2024 | 123.0% | $276.09 Million | $224.53 Million | $356.70 Million | $80.61 Million | ▲ +11.7 pp |
| 2023 | 111.3% | $219.19 Million | $196.99 Million | $256.13 Million | $36.94 Million | ▲ +2.4 pp |
| 2022 | 108.8% | $209.95 Million | $192.90 Million | $225.38 Million | $15.43 Million | ▲ +10.2 pp |
| 2021 | 98.6% | $164.47 Million | $166.73 Million | $175.95 Million | $11.48 Million | ▼ -0.9 pp |
| 2020 | 99.6% | $165.27 Million | $165.98 Million | $170.66 Million | $5.39 Million | ▲ +1052.3 pp |
| 2019 | -952.7% | $57.21 Million | $-6.00 Million | $58.03 Million | $819.00K | ▼ -789.9 pp |
| 2018 | -162.8% | $2.20 Million | $-1.35 Million | $2.38 Million | $179.00K | — |